{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:04:24Z","timestamp":1789653864179,"version":"4.0.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Conventional chemotherapeutic treatment of colorectal cancer causes adverse effects such as severe diarrhoea, mucositis and hepatotoxicity. This study aimed to investigate the anti-carcinogenic potential of epigallocatechin-3-gallate and its effects on major angiogenic markers, alone and in combination with irinotecan in colorectal cancer model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Colorectal cancer was induced in mice by injecting azoxymethane and oral administration of dextran sulfate sodium in drinking water as described previously. After 16th week of experimentation, animals were sacrificed, morphometrical assessment was conducted and tissues were processed for histopathological, immunohistochemical and gene expression analysis by qRT-PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results showed reduction in tumour count, alleviation of colorectal cancer symptoms, improvement in histopathological alterations and goblet cell count with combination therapy. Suppression of key oncogenic and angiogenic markers and reduction in liver injury with combination treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combined treatment of epigallocatechin-3-gallate with irinotecan enhanced the anti-tumour potential of irinotecan, and inhibited cancer progression and expression of tumour-associated angiogenesis markers. Moreover, treatment associated liver injury was also reduced by epigallocatechin-3-gallate supplementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00412-4","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:30:16Z","timestamp":1789651816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigallocatechin-3-Gallate, the green tea polyphenol suppresses expression of CD31 and VEGFR2 and enhances the chemotherapeutic potential of irinotecan in AOM\/DSS model of colorectal cancer in mice"],"prefix":"10.1186","volume":"38","author":[{"given":"Sabana Sargam","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Baruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Akhtara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydeep Kumar","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuj Kumar","family":"Bharali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"3","key":"412_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Cancer J Clin"},{"issue":"2","key":"412_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/pg.2018.81072","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przeglad gastroenterologiczny. 2019;14(2):89\u2013103. https:\/\/doi.org\/10.5114\/pg.2018.81072.","journal-title":"Przeglad gastroenterologiczny"},{"issue":"5","key":"412_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/JCO.2001.19.5.1501","volume":"19","author":"U Vanhoefer","year":"2001","unstructured":"Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM. Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol. 2001;19(5):1501\u201318. https:\/\/doi.org\/10.1200\/JCO.2001.19.5.1501.","journal-title":"J Clin Oncol"},{"issue":"4","key":"412_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","volume":"15","author":"A Kumar","year":"2023","unstructured":"Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J Gastrointest Surg. 2023;15(4):495\u2013519. https:\/\/doi.org\/10.4240\/wjgs.v15.i4.495.","journal-title":"World J Gastrointest Surg"},{"key":"412_CR5","doi-asserted-by":"publisher","first-page":"114304","DOI":"10.1016\/j.ejmech.2022.114304","volume":"236","author":"A Talukdar","year":"2022","unstructured":"Talukdar A, Kundu B, Sarkar D, Goon S, Mondal MA. Topoisomerase I inhibitors: Challenges, progress and the road ahead. Eur J Med Chem. 2022;236:114304. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114304.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"412_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00418-025-02444-8","volume":"163","author":"S Baruah","year":"2025","unstructured":"Baruah S, Rahman SS, Akhtara N, Nath JK, Mishra R, Bharali MK. Sarco\/endoplasmic reticulum calcium ATPase expression in AOM\/DSS model of colon carcinogenesis in mice. Histochem Cell Biol. 2025;163(1):123. https:\/\/doi.org\/10.1007\/s00418-025-02444-8.","journal-title":"Histochem Cell Biol"},{"issue":"7","key":"412_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2174\/1389450111314070007","volume":"14","author":"U Swami","year":"2013","unstructured":"Swami U, Goel S, Mani S. Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis. Curr Drug Targets. 2013;14(7):777\u201397. https:\/\/doi.org\/10.2174\/1389450111314070007.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"412_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/md22070328","volume":"22","author":"SO Hassanin","year":"2024","unstructured":"Hassanin SO, Hegab AMM, Mekky RH, Said MA, Khalil MG, Hamza AA, Amin A. Combining In Vitro, In Vivo, and Network Pharmacology Assays to Identify Targets and Molecular Mechanisms of Spirulina-Derived Biomolecules against Breast Cancer. Mar Drugs. 2024;22(7):328. https:\/\/doi.org\/10.3390\/md22070328.","journal-title":"Mar Drugs"},{"issue":"2","key":"412_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/ph18020248","volume":"18","author":"AMM Hegab","year":"2025","unstructured":"Hegab AMM, Hassanin SO, Mekky RH, Abuzahrah SS, Hamza AA, Talaat IM, Amin A. Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1\/Nrf2, Oxidative Stress, Inflammation, and Apoptosis. Pharmaceuticals. 2025;18(2):248. https:\/\/doi.org\/10.3390\/ph18020248.","journal-title":"Pharmaceuticals"},{"key":"412_CR10","doi-asserted-by":"publisher","first-page":"938471","DOI":"10.3389\/fphar.2022.938471","volume":"13","author":"L Lozon","year":"2022","unstructured":"Lozon L, Saleh E, Menon V, Ramadan WS, Amin A, El-Awady R. Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter? Front Pharmacol. 2022;13:938471. https:\/\/doi.org\/10.3389\/fphar.2022.938471.","journal-title":"Front Pharmacol"},{"key":"412_CR11","doi-asserted-by":"publisher","first-page":"1528978","DOI":"10.3389\/fphar.2025.1528978","volume":"16","author":"R Ismail","year":"2025","unstructured":"Ismail R, Habib HA, Anter AF, Amin A, Heeba GH. Modified citrus pectin ameliorates methotrexate-induced hepatic and pulmonary toxicity: role of Nrf2, galectin-3\/TLR-4\/NF-\u03baB\/TNF-\u03b1 and TGF-\u03b2 signaling pathways. Front Pharmacol. 2025;16:1528978. https:\/\/doi.org\/10.3389\/fphar.2025.1528978.","journal-title":"Front Pharmacol"},{"issue":"1","key":"412_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/hm9.0000000000000008","volume":"1","author":"L Nurtay","year":"2021","unstructured":"Nurtay L, Sun Q, Mu C, Cao Z, Wang Q, Liang Z, Ma C, Li X, Amin A, Xie Y. Rhizoma polygonati from Mount Tai: nutritional value and usefulness as a traditional Chinese medicine, source of herbzyme, and potential remediating agent for COVID-19 and chronic and hidden hunger. Acupunct Herb Med. 2021;1(1):31\u20138. https:\/\/doi.org\/10.1097\/hm9.0000000000000008.","journal-title":"Acupunct Herb Med"},{"key":"412_CR13","doi-asserted-by":"publisher","first-page":"710304","DOI":"10.3389\/fphar.2021.710304","volume":"12","author":"MH Ch\u00e1irez-Ram\u00edrez","year":"2021","unstructured":"Ch\u00e1irez-Ram\u00edrez MH, de la Cruz-L\u00f3pez KG, Garc\u00eda-Carranc\u00e1 A. Polyphenols as antitumor agents targeting key players in cancer-driving signaling pathways. Front Pharmacol. 2021;12:710304. https:\/\/doi.org\/10.3389\/fphar.2021.710304.","journal-title":"Front Pharmacol"},{"issue":"9","key":"412_CR14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/ph17091208","volume":"17","author":"S Bouabdallah","year":"2024","unstructured":"Bouabdallah S, Ibrahim MH, Brinza I, Boiangiu RS, Honceriu I, Amin A, Ben-Attia M, Hritcu L. Anxiolytic and Antidepressant Effects of Tribulus terrestris Ethanolic Extract in Scopolamine-Induced Amnesia in Zebrafish: Supported by Molecular Docking Investigation Targeting Monoamine Oxidase A. Pharmaceuticals. 2024;17(9):1208. https:\/\/doi.org\/10.3390\/ph17091208.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"412_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/ph17020200","volume":"17","author":"S Bouabdallah","year":"2024","unstructured":"Bouabdallah S, Brinza I, Boiangiu RS, Ibrahim MH, Honceriu I, Al-Maktoum A, Cioanca O, Hancianu M, Amin A, Ben-Attia M, Hritcu L. The Effect of a Tribulus-Based Formulation in Alleviating Cholinergic System Impairment and Scopolamine-Induced Memory Loss in Zebrafish (Danio rerio): Insights from Molecular Docking and In Vitro\/In Vivo Approaches. Pharmaceuticals. 2024;17(2):200. https:\/\/doi.org\/10.3390\/ph17020200.","journal-title":"Pharmaceuticals"},{"key":"412_CR16","doi-asserted-by":"publisher","first-page":"850066","DOI":"10.3389\/fphar.2022.850066","volume":"13","author":"R Abdel-Latif","year":"2022","unstructured":"Abdel-Latif R, Heeba GH, Hassanin SO, Waz S, Amin A. TLRS-JNK\/ NF-\u039aB pathway underlies the protective effect of the sulfide salt against liver toxicity. Front Pharmacol. 2022;13:850066. https:\/\/doi.org\/10.3389\/fphar.2022.850066.","journal-title":"Front Pharmacol"},{"issue":"1","key":"412_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/ijms24010340","volume":"24","author":"D Mokra","year":"2022","unstructured":"Mokra D, Joskova M, Mokry J. Therapeutic effects of green tea polyphenol (\u2013)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis. Int J Mol Sci. 2022;24(1):340. https:\/\/doi.org\/10.3390\/ijms24010340.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"412_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/molecules30030654","volume":"30","author":"L Capasso","year":"2025","unstructured":"Capasso L, De Masi L, Sirignano C, Maresca V, Basile A, Nebbioso A, Bontempo P. Epigallocatechin gallate (EGCG): Pharmacological properties, biological activities and therapeutic potential. Molecules. 2025;30(3):654. https:\/\/doi.org\/10.3390\/molecules30030654.","journal-title":"Molecules"},{"key":"412_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43046-021-00074-4","volume":"33","author":"G Borah","year":"2021","unstructured":"Borah G, Bharali MK. Green tea catechins in combination with irinotecan attenuates tumorigenesis and treatment-associated toxicity in an inflammation-associated colon cancer mice model. J Egypt Natl Canc Inst. 2021;33:17. https:\/\/doi.org\/10.1186\/s43046-021-00074-4.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"3","key":"412_CR20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/cas.16063","volume":"115","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zhang X, Bai X, Xi X, Liu W, Zhong W. Anti-angiogenesis in colorectal cancer therapy. Cancer Sci. 2024;115(3):734\u201351. https:\/\/doi.org\/10.1111\/cas.16063.","journal-title":"Cancer Sci"},{"issue":"8","key":"412_CR21","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1158\/0008-5472.can-11-3406","volume":"72","author":"B Sitohy","year":"2012","unstructured":"Sitohy B, Nagy JA, Dvorak HF. Anti-VEGF\/VEGFR therapy for cancer: Reassessing the target. Cancer Res. 2012;72(8):1909\u201314. https:\/\/doi.org\/10.1158\/0008-5472.can-11-3406.","journal-title":"Cancer Res"},{"issue":"40","key":"412_CR22","doi-asserted-by":"publisher","first-page":"e8242","DOI":"10.1097\/md.0000000000008242","volume":"96","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Chen Z, Li J. The current status of treatment for colorectal cancer in China. Medicine. 2017;96(40):e8242. https:\/\/doi.org\/10.1097\/md.0000000000008242.","journal-title":"Medicine"},{"issue":"8","key":"412_CR23","doi-asserted-by":"publisher","first-page":"e70735","DOI":"10.1002\/fsn3.70735","volume":"13","author":"AM Noman","year":"2025","unstructured":"Noman AM, Sultan MT, Mazhar A, Baig I, Javaid J, Hussain M, Imran M, Alsagaby SA, Abdulmonem A, Mujtaba W, Yehuala A, Ghoneim TF, Mostafa MM, E. M., Abdelgawad MA. Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials. Food Sci Nutr. 2025;13(8):e70735. https:\/\/doi.org\/10.1002\/fsn3.70735.","journal-title":"Food Sci Nutr"},{"issue":"11","key":"412_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1349-7006.2003.tb01386.x","volume":"94","author":"T Tanaka","year":"2003","unstructured":"Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003;94(11):965\u201373. https:\/\/doi.org\/10.1111\/j.1349-7006.2003.tb01386.x.","journal-title":"Cancer Sci"},{"key":"412_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-34567-2","author":"S Baruah","year":"2026","unstructured":"Baruah S, Bharali MK, Akhtara N, Nath JK, Rahman SS, Rasid SS, Baidya M, Khan EMMS, Mishra R. Thapsigargin enhanced chemotherapeutic sensitivity of irinotecan in the inflammation-induced colorectal cancer model in mice. Sci Rep. 2026. https:\/\/doi.org\/10.1038\/s41598-025-34567-2.","journal-title":"Sci Rep"},{"key":"412_CR26","doi-asserted-by":"publisher","first-page":"606123","DOI":"10.3389\/fcell.2020.606123","volume":"8","author":"KW Luo","year":"2020","unstructured":"Luo KW, Zhu XH, Zhao T, Zhong J, Gao HC, Luo XL, Huang WR. EGCG enhanced the anti-tumor effect of doxorubicine in bladder cancer via NF-\u03baB\/MDM2\/p53 pathway. Front Cell Dev Biology. 2020;8:606123. https:\/\/doi.org\/10.3389\/fcell.2020.606123.","journal-title":"Front Cell Dev Biology"},{"issue":"4","key":"412_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/nu14040726","volume":"14","author":"J Deng","year":"2022","unstructured":"Deng J, Zhao L, Yuan X, Li Y, Shi J, Zhang H, Zou F. Pre-administration of berberine exerts chemopreventive effects in AOM\/DSS-induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota. Nutrients. 2022;14(4):726. https:\/\/doi.org\/10.3390\/nu14040726.","journal-title":"Nutrients"},{"key":"412_CR28","doi-asserted-by":"publisher","first-page":"797605","DOI":"10.3389\/fphar.2021.797605","volume":"12","author":"M Wang","year":"2021","unstructured":"Wang M, Zhou B, Cong W, Zhang M, Li Z, Li Y, Wu Z. Amelioration of AOM\/DSS-induced murine colitis-associated cancer by evodiamine intervention is primarily associated with gut microbiota-metabolism-inflammatory signaling axis. Front Pharmacol. 2021;12:797605. https:\/\/doi.org\/10.3389\/fphar.2021.797605.","journal-title":"Front Pharmacol"},{"key":"412_CR29","doi-asserted-by":"publisher","first-page":"679806","DOI":"10.3389\/fcell.2021.679806","volume":"9","author":"W Cao","year":"2021","unstructured":"Cao W, Li Y, Sun H, Yang C, Zhu J, Xie C, Li X, Wu J, Geng S, Wang L, Sun L, Geng G, Han H, Zhong C. Apatinib suppresses gastric cancer stem cells properties by inhibiting the sonic hedgehog pathway. Front Cell Dev Biology. 2021;9:679806. https:\/\/doi.org\/10.3389\/fcell.2021.679806.","journal-title":"Front Cell Dev Biology"},{"key":"412_CR30","doi-asserted-by":"publisher","first-page":"137037","DOI":"10.1016\/j.jhazmat.2024.137037","volume":"486","author":"H Yu","year":"2024","unstructured":"Yu H, Zhang W, Wang D, Shi B, Zhu Y, Hu W, He J, Hong J, Xu X, Zheng X, Chen W, Wang F, Qu F. Exposure to 6PPD-Q induces dysfunctions of ovarian granulosa cells: Its potential role in PCOS. J Hazard Mater. 2024;486:137037. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.137037.","journal-title":"J Hazard Mater"},{"issue":"14","key":"412_CR31","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/cells13141210","volume":"13","author":"G Corsetti","year":"2024","unstructured":"Corsetti G, Romano C, Codenotti S, Giugno L, Pasini E, Fanzani A, Scarabelli T, Dioguardi FS. Intake of special amino acids mixture leads to blunted murine colon cancer growth in vitro and in vivo. Cells. 2024;13(14):1210. https:\/\/doi.org\/10.3390\/cells13141210.","journal-title":"Cells"},{"issue":"1","key":"412_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41368-025-00347-x","volume":"17","author":"X Zhao","year":"2025","unstructured":"Zhao X, Zheng X, Wang Y, Chen J, Wang X, Peng X, Yuan D, Liu Y, Wang Z, Du J. Administration of Porphyromonas gingivalis in pregnant mice enhances glycolysis and histone lactylation\/ADAM17 leading to cleft palate in offspring. Int J Oral Sci. 2025;17(1):18. https:\/\/doi.org\/10.1038\/s41368-025-00347-x.","journal-title":"Int J Oral Sci"},{"issue":"11","key":"412_CR33","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.bbamcr.2014.08.002","volume":"1843","author":"L Lipskaia","year":"2014","unstructured":"Lipskaia L, Keuylian Z, Blirando K, Mougenot N, Jacquet A, Rouxel C, Sghairi H, Elaib Z, Blaise R, Adnot S, Hajjar RJ, Chemaly ER, Limon I, Bobe R. Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis. Biochimica Et Biophysica Acta (BBA) -. Mol Cell Res. 2014;1843(11):2705\u201318. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.08.002.","journal-title":"Mol Cell Res"},{"issue":"6","key":"412_CR34","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4103\/1008-682X.157396","volume":"17","author":"K Wang","year":"2015","unstructured":"Wang K, Li N, Yeung CH, Cooper TG, Liu XX, Liu J, Wang WT, Li Y, Shi H, Liu FJ. Comparison of gene expression of the oncogenic Wnt\/\u03b2-catenin signaling pathway components in the mouse and human epididymis. Asian J Androl. 2015;17(6):1006\u201311. https:\/\/doi.org\/10.4103\/1008-682X.157396.","journal-title":"Asian J Androl"},{"key":"412_CR35","doi-asserted-by":"publisher","first-page":"1345516","DOI":"10.3389\/fphar.2024.1345516","volume":"15","author":"BS Alotaibi","year":"2024","unstructured":"Alotaibi BS, El-Masry TA, Selim H, El-Bouseary MM, El-Sheekh MM, Makhlof MEM, El-Nagar MMF. New insights into the anticancer effects of Polycladia crinita aqueous extract and its selenium nanoformulation against the solid Ehrlich carcinoma model in mice via VEGF, notch 1, NF-\u043aB, cyclin D1, and caspase 3 signaling pathway. Front Pharmacol. 2024;15:1345516. https:\/\/doi.org\/10.3389\/fphar.2024.1345516.","journal-title":"Front Pharmacol"},{"issue":"1","key":"412_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13578-022-00880-w","volume":"12","author":"W Song","year":"2022","unstructured":"Song W, Zhang D, Mi J, Du W, Yang Y, Chen R, Tian C, Zhao X, Zou K. E-cadherin maintains the undifferentiated state of mouse spermatogonial progenitor cells via \u03b2-catenin. Cell Bioscience. 2022;12(1):141. https:\/\/doi.org\/10.1186\/s13578-022-00880-w.","journal-title":"Cell Bioscience"},{"key":"412_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.toxlet.2020.10.007","volume":"335","author":"F Otaka","year":"2020","unstructured":"Otaka F, Ito Y, Goto T, Eshima K, Amano H, Koizumi W, Majima M. Platelets prevent the development of monocrotaline-induced liver injury in mice. Toxicol Lett. 2020;335:71\u201381. https:\/\/doi.org\/10.1016\/j.toxlet.2020.10.007.","journal-title":"Toxicol Lett"},{"issue":"2","key":"412_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.34172\/apb.2020.039","volume":"10","author":"S Malekian","year":"2020","unstructured":"Malekian S, Rahmati M, Sari S, Kazemimanesh M, Kheirbakhsh R, Muhammadnejad A, Amanpour S. Expression of Diverse Angiogenesis Factor in Different Stages of the 4T1 Tumor as a Mouse Model of Triple-Negative Breast Cancer. Adv Pharm Bull. 2020;10(2):323\u20138. https:\/\/doi.org\/10.34172\/apb.2020.039.","journal-title":"Adv Pharm Bull"},{"issue":"6","key":"412_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1200\/jop.0852002","volume":"4","author":"KM Field","year":"2008","unstructured":"Field KM, Kosmider S, Jefford M, Jennens R, Green M, Gibbs P. Chemotherapy treatments for metastatic colorectal cancer: Is Evidence-Based Medicine in practice? J Oncol Pract. 2008;4(6):271\u20136. https:\/\/doi.org\/10.1200\/jop.0852002.","journal-title":"J Oncol Pract"},{"key":"412_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.phrs.2018.11.005","volume":"139","author":"H Batra","year":"2018","unstructured":"Batra H, Pawar S, Bahl D. Curcumin in combination with anti-cancer drugs: A nanomedicine review. Pharmacol Res. 2018;139:91\u2013105. https:\/\/doi.org\/10.1016\/j.phrs.2018.11.005.","journal-title":"Pharmacol Res"},{"key":"412_CR41","doi-asserted-by":"publisher","first-page":"113384","DOI":"10.1016\/j.biopha.2022.113384","volume":"153","author":"A Esmeeta","year":"2022","unstructured":"Esmeeta A, Adhikary S, Dharshnaa V, Swarnamughi P, Maqsummiya ZU, Banerjee A, Pathak S, Duttaroy AK. Plant-derived bioactive compounds in colon cancer treatment: An updated review. Biomed Pharmacother. 2022;153:113384. https:\/\/doi.org\/10.1016\/j.biopha.2022.113384.","journal-title":"Biomed Pharmacother"},{"key":"412_CR42","doi-asserted-by":"publisher","first-page":"132135","DOI":"10.1016\/j.foodchem.2022.132135","volume":"379","author":"M Alam","year":"2022","unstructured":"Alam M, Ali S, Ashraf GM, Bilgrami AL, Yadav DK, Hassan MI. Epigallocatechin 3-gallate: From green tea to cancer therapeutics. Food Chem. 2022;379:132135. https:\/\/doi.org\/10.1016\/j.foodchem.2022.132135.","journal-title":"Food Chem"},{"issue":"4","key":"412_CR43","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/molecules26041109","volume":"26","author":"CA Dehelean","year":"2021","unstructured":"Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, Cretu OM, Pinzaru I. Plant-Derived Anticancer Compounds as new perspectives in drug discovery and alternative therapy. Molecules. 2021;26(4):1109. https:\/\/doi.org\/10.3390\/molecules26041109.","journal-title":"Molecules"},{"issue":"4","key":"412_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/jox16040120","volume":"16","author":"A Fahmy","year":"2026","unstructured":"Fahmy A, Hegab AMM, Mossalem HS, Abuzahrah SS, Alafghani SO, Hamza AA, Juaid N, Amin A. Safranal Enhances the Efficacy of Praziquantel Against Schistosoma mansoni Infection and Alleviates Liver Fibrosis, Inflammation and Oxidative Stress in Mice. J Xenobiotics. 2026b;16(4):120. https:\/\/doi.org\/10.3390\/jox16040120.","journal-title":"J Xenobiotics"},{"key":"412_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05573-6","author":"AA Mansoori","year":"2026","unstructured":"Mansoori AA, Baig B, Harati R, Alhamidi RS, Hamza AA, Al-Salam S, Le A, Zhang C, Khare P, Hamoudi R, Amin A. Safranal improves the anticancer efficacy of sorafenib via transcriptomic reprogramming and metabolomic changes in a rat model of diethylnitrosamine-induced cirrhosis\u2013hepatocellular carcinoma. Naunyn-Schmiedeberg S Archives Pharmacol. 2026. https:\/\/doi.org\/10.1007\/s00210-026-05573-6.","journal-title":"Naunyn-Schmiedeberg S Archives Pharmacol"},{"issue":"3","key":"412_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/ph19030458","volume":"19","author":"S Bouabdallah","year":"2026","unstructured":"Bouabdallah S, Kouki A, Ibrahim MH, Brinza I, Boiangiu RS, Ben-Attia M, Hritcu L, Amin A. Behavioral, Biochemical, and In Silico Evidence for Extraction-Dependent Neuroprotective Effects of Citrus limon Leaf Essential Oils in Scopolamine-Challenged Zebrafish. Pharmaceuticals. 2026;19(3):458. https:\/\/doi.org\/10.3390\/ph19030458.","journal-title":"Pharmaceuticals"},{"issue":"23","key":"412_CR47","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022\u201343. https:\/\/doi.org\/10.18632\/oncotarget.16723.","journal-title":"Oncotarget"},{"key":"412_CR48","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ejmech.2017.12.039","volume":"144","author":"A Rejhov\u00e1","year":"2017","unstructured":"Rejhov\u00e1 A, Opattov\u00e1 A, \u010cumov\u00e1 A, Sl\u00edva D, Vodi\u010dka P. Natural compounds and combination therapy in colorectal cancer treatment. Eur J Med Chem. 2017;144:582\u201394. https:\/\/doi.org\/10.1016\/j.ejmech.2017.12.039.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"412_CR49","doi-asserted-by":"publisher","first-page":"22390","DOI":"10.1038\/srep22390","volume":"6","author":"J Meng","year":"2016","unstructured":"Meng J, Guo F, Xu H, Liang W, Wang C, Yang X. Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo. Sci Rep. 2016;6(1):22390. https:\/\/doi.org\/10.1038\/srep22390.","journal-title":"Sci Rep"},{"issue":"8","key":"412_CR50","doi-asserted-by":"publisher","first-page":"110434","DOI":"10.1016\/j.isci.2024.110434","volume":"27","author":"H Ji","year":"2024","unstructured":"Ji H, Zhang Z, Chen C, Xu W, Liu T, Dong Y, Wang J, Wang H, Zhu X. The impact of quercetin and paclitaxel combination on ovarian cancer cells. iScience. 2024;27(8):110434. https:\/\/doi.org\/10.1016\/j.isci.2024.110434.","journal-title":"iScience"},{"issue":"16","key":"412_CR51","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1111\/jcmm.16718","volume":"25","author":"W Wu","year":"2021","unstructured":"Wu W, Dong J, Gou H, Geng R, Yang X, Chen D, Xiang B, Zhang Z, Ren S, Chen L, Liu J. EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells. J Cell Mol Med. 2021;25(16):7913\u201321. https:\/\/doi.org\/10.1111\/jcmm.16718.","journal-title":"J Cell Mol Med"},{"key":"412_CR52","doi-asserted-by":"publisher","unstructured":"Klinski E. Block Copolymer Based Composition of Epigallocatechin-3-gallate with Improved Oral Bioavailability as a Way to Increase its Therapeutic Activity. J Nanomed Biotherapeutic Discovery. 2013;03(02). https:\/\/doi.org\/10.4172\/2155-983x.1000117.","DOI":"10.4172\/2155-983x.1000117"},{"issue":"3","key":"412_CR53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000055379","volume":"61","author":"T Utsunomiya","year":"2001","unstructured":"Utsunomiya T, Doki Y, Takemoto H, Shiozaki H, Yano M, Sekimoto M, Tamura S, Yasuda T, Fujiwara Y, Monden M. Correlation of beta-catenin and cyclin D1 expression in colon cancers. Oncology. 2001;61(3):226\u201333. https:\/\/doi.org\/10.1159\/000055379.","journal-title":"Oncology"},{"key":"412_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1124\/jpet.122.538060","volume":"385","author":"JD Godavarthi","year":"2023","unstructured":"Godavarthi JD, Williams-Villalobo A, Etim I, Ting D, Gao S, Zhang Y. The synergistic antitumor effect of irinotecan and flavonoids on human colon cancer xenograft mice. J Pharmacol Exp Ther. 2023;385:44. https:\/\/doi.org\/10.1124\/jpet.122.538060.","journal-title":"J Pharmacol Exp Ther"},{"key":"412_CR55","doi-asserted-by":"publisher","first-page":"103850","DOI":"10.1016\/j.amsu.2022.103850","volume":"78","author":"S Zeynali-Moghaddam","year":"2022","unstructured":"Zeynali-Moghaddam S, Kheradmand F, Aziz SG, Abroon S. Combination effects of capecitabine, irinotecan and 17-AAG on colorectal cancer cell line (HT-29). Annals Med Surg. 2022;78:103850. https:\/\/doi.org\/10.1016\/j.amsu.2022.103850.","journal-title":"Annals Med Surg"},{"key":"412_CR56","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3892\/ol.2017.6641","volume":"14","author":"C Huang","year":"2017","unstructured":"Huang C, Han Z, Li X, Xie H, Zhu S. Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer. Oncol Lett. 2017;14:3623\u20137. https:\/\/doi.org\/10.3892\/ol.2017.6641.","journal-title":"Oncol Lett"},{"issue":"1","key":"412_CR57","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Chen H, Zheng L, Sun L, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Therapy. 2023;8(1):198. https:\/\/doi.org\/10.1038\/s41392-023-01460-1.","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"412_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2004.04.03","volume":"213","author":"HC Lai","year":"2004","unstructured":"Lai HC, Chao WT, Chen YT, Yang VC. Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro. Cancer Lett. 2004;213(2):181\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2004.04.03.","journal-title":"Cancer Lett"},{"issue":"10","key":"412_CR59","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/j.1349-7006.2009.01241.x","volume":"100","author":"Y Shirakami","year":"2009","unstructured":"Shirakami Y, Shimizu M, Adachi S, Sakai H, Nakagawa T, Yasuda Y, Tsurumi H, Hara Y, Moriwaki H. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Sci. 2009;100(10):1957\u201362. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01241.x.","journal-title":"Cancer Sci"},{"issue":"3","key":"412_CR60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10549-008-0196-x","volume":"117","author":"H Leong","year":"2009","unstructured":"Leong H, Mathur PS, Greene GL. Green tea catechins inhibit angiogenesis through suppression of STAT3 activation. Breast Cancer Res Treat. 2009;117(3):505\u201315. https:\/\/doi.org\/10.1007\/s10549-008-0196-x.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"412_CR61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-824X-5-9","volume":"5","author":"JW Gu","year":"2013","unstructured":"Gu JW, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, Thomas EY, Miele L. EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1\u03b1 and NF\u03baB, and VEGF expression. Vascular cell. 2013;5(1):9. https:\/\/doi.org\/10.1186\/2045-824X-5-9.","journal-title":"Vascular cell"},{"key":"412_CR62","doi-asserted-by":"publisher","first-page":"1516449","DOI":"10.3389\/fphar.2025.1516449","volume":"16","author":"S Lou","year":"2025","unstructured":"Lou S, Chen H, Cui Z, Zhang X, Zhu C, Zhou L, Ou Y, Zou F. Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004\u20132024. Front Pharmacol. 2025;16:1516449. https:\/\/doi.org\/10.3389\/fphar.2025.1516449.","journal-title":"Front Pharmacol"},{"key":"412_CR63","doi-asserted-by":"publisher","first-page":"754891","DOI":"10.3389\/fonc.2021.754891","volume":"11","author":"J Han","year":"2021","unstructured":"Han J, Zhang J, Zhang C. Irinotecan-Induced Steatohepatitis: Current Insights. Front Oncol. 2021;11:754891. https:\/\/doi.org\/10.3389\/fonc.2021.754891.","journal-title":"Front Oncol"},{"key":"412_CR64","doi-asserted-by":"publisher","unstructured":"Mansoor N, Khan RA, Schueller J, Ettlinge D, Buchner P, Czejka M, Ahmad T. Irinotecan (CamptoR) Pharmacokinetics and Metabolism in Patients with Elevated Serum Bilirubin Levels. J Cancer Res Updates. 2016;5(2). https:\/\/doi.org\/10.6000\/1929-2279.2016.05.02.4.","DOI":"10.6000\/1929-2279.2016.05.02.4"},{"key":"412_CR65","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12944-025-02596-5","volume":"24","author":"J Zhang","year":"2025","unstructured":"Zhang J, Wang S, Zhang T, Zi M, Wang S, Zhang Q Green tea epigallocatechin gallate attenuate metabolic dysfunction-associated steatotic liver disease by regulation of pyroptosis. Lipids Health Dis. 2025;24:180. https:\/\/doi.org\/10.1186\/s12944-025-02596-5.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"412_CR66","doi-asserted-by":"publisher","first-page":"9566","DOI":"10.1038\/s41598-025-93120-3","volume":"15","author":"MaM Ali","year":"2025","unstructured":"Ali MaM, Matouk AI, Hamza AA, Amin A, Heeba GH. Gallic and glycyrrhetinic acids prevent azithromycin-induced liver damage in rats by mitigating oxidative stress and inflammation. Sci Rep. 2025;15(1):9566. https:\/\/doi.org\/10.1038\/s41598-025-93120-3.","journal-title":"Sci Rep"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00412-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00412-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00412-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:30:17Z","timestamp":1789651817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00412-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00412-4","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"25 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This experiment was performed following the guidelines of the Institutional Animal Ethical Committee (IAEC), Gauhati University (IAEC\/ Per\/2024\/PP-IAEC\/ 2024-8-8\/8).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"73"}}